Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppressive therapy for external ocular inflammatory disease

C S Foster

    Ophthalmology
    |February 1, 1980
    PubMed
    Summary

    Systemic immunosuppression effectively controlled progressive ocular inflammation and destructive lesions in patients unresponsive to standard treatments. This approach showed promising results for conditions like cicatricial pemphigoid and Mooren's corneal ulcers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.

    British journal of cancer·2014
    Same author

    Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.

    Prostate cancer and prostatic diseases·2012
    Same author

    Atopic keratoconjunctivitis.

    Ocular immunology and inflammation·2012
    Same author

    Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer.

    British journal of cancer·2012
    Same author

    Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

    British journal of cancer·2012
    Same author

    Difluprednate for inflammatory eye disorders.

    Drugs of today (Barcelona, Spain : 1998)·2011

    Area of Science:

    • Ophthalmology
    • Rheumatology
    • Immunology

    Background:

    • Progressive ocular inflammation and destructive lesions pose significant challenges in ophthalmology.
    • Conventional therapies often fail to manage severe cases, necessitating alternative treatment strategies.

    Observation:

    • Fourteen patients with severe, treatment-resistant ocular conditions were studied.
    • Patient diagnoses included connective tissue/vasculitis diseases, cicatricial pemphigoid, and bilateral Mooren's corneal ulcers.

    Findings:

    • Systemic immunosuppression led to consistent control of ocular inflammation and tissue destruction across all patients.
    • Encouraging outcomes were observed in patients with cicatricial pemphigoid and Mooren's ulcers.

    Implications:

    • Systemic immunosuppression is a viable and effective treatment for refractory ocular inflammatory and destructive diseases.
    • This therapeutic strategy offers hope for patients with severe autoimmune and inflammatory eye conditions.

    Related Experiment Videos